8-letter .com brandable for the GLP-1 era. Invented in the Ozempic / Mounjaro / Wegovy phonetic family — engineered for a telehealth weight-loss platform, metabolic health clinic, or obesity-care brand entering the $100B GLP-1 market.
Perfect For
- GLP-1 telehealth platform (semaglutide / tirzepatide / compounded)
- Metabolic health clinic or coaching app
- Pharmaceutical or nutraceutical brand for obesity care
- CGM-powered AI metabolic coaching service
If This Were Your Brand
Catalyxi was invented to slot into the Ozempic / Mounjaro / Wegovy market — a name that already sounds like a real pharmaceutical brand. Here's how it could look in a member app and on the product itself.
Why $20,000
What anchors a $20,000 valuation for an invented pharma brandable in the GLP-1 era:
Catalyxi sits mid-band on aftermarket pricing despite a stronger category tailwind than most names in that range — and you skip the $50K-$250K naming-agency exercise entirely. Trademark-clean as of listing; we'll provide a fresh USPTO search before purchase on request.
What's Included
- Catalyxi.com — full ownership transfer to your registrar
- Escrow.com transaction protection (3.25% fee, typically buyer-paid)
- Free DNS setup assistance via Cloudflare
- Full transfer support — most complete within 24-48 hours
- 30-day satisfaction guarantee
- Confidentiality: your purchase details stay private
Start a Conversation
Chat directly with our AI-assisted negotiation bot. Make an offer, ask questions, or start an Escrow transaction on the spot.
Or Email Us Directly
Inquiries go to [email protected] — we reply within 4 hours.